Top 10 Companies Combining AI and Drug Discovery in Europe
Rapid advances in artificial intelligence over the last decade have the potential to revolutionize how…
Rapid advances in artificial intelligence over the last decade have the potential to revolutionize how…
The rapid spread of Covid-19 around the world has left drug developers with limited time…
UK-based Exscientia has closed a Series C financing round of €54M ($60M) to develop its…
The AI-driven drug repurposing company Healx has teamed up with the global Children’s Tumor Foundation…
The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection…
Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes…
French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new…
A drug designed by the UK firm Exscientia using AI-powered software has entered into a…
Artificial intelligence has been much discussed of late, but will it really help us solve…
The Cambridge-based artificial intelligence company Healx has raised a Series B round of €50.8M to…
Artificial intelligence promises to use the power of data to solve some of the biggest…
The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop…